Завершено
Фаза III
Беларусь
ДИНАТРИЯ ФОСТАМАТИНИБ (R935788) · Regel Pharmaceuticals, Inc.
A Phase 3 Open Label Extension Study of Fostamatinib Disodium in the Treatment of Warm Antibody Autoimmune Hemolytic Anemia